Circulating cytokines in sarcoidosis: Phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease |
| |
| Authors: | Karen C Patterson Beverly S Franek Joachim Müller-Quernheim Anne I Sperling Nadera J Sweiss Timothy B Niewold |
| |
| Institution: | 1. Section of Pulmonary and Critical Care, University of Chicago, Chicago, IL, United States;2. Section of Rheumatology, University of Chicago, Chicago, IL, United States;3. Gwen Knapp Center for Lupus and Immunology Research, Chicago, IL, United States;4. Department of Pneumology, University Medical Center, Albert Ludwigs University, Freiburg, Germany;5. Committee on Immunology, University of Chicago, Chicago, IL, United States;6. Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, United States |
| |
| Abstract: | AimsSarcoidosis is a granulomatous disease of unknown etiology marked by tremendous clinical heterogeneity. Many patients enter remission with good long-term outcomes. Yet, chronic disease is not uncommon, and this important phenotype remains understudied. Identified alterations in local and circulating cytokines—specifically targeted for study, and often in the acute phase of disease—have informed our growing understanding of the immunopathogenesis of sarcoidosis. Our aim was to evaluate a broad panel of circulating cytokines in patients with chronic sarcoidosis. Among those with chronic disease, pulmonary fibrosis occurs in only a subset. To gain more insight into the determinants of the fibrotic response, we also determined if the phenotypes of fibrotic and non-fibrotic pulmonary sarcoidosis have distinct cytokine profiles.ResultsIn patients with sarcoidosis compared to controls, IL-5 was decreased, and IL-7 was increased. Both of these comparisons withstood rigorous statistical correction for multiple comparisons. GM-CSF met a nominal level of significance. We also detected an effect of phenotype, where IL-5 was significantly decreased in non-fibrotic compared to fibrotic pulmonary sarcoidosis, and compared to controls. Compared to controls, there was a trend towards a significant increase in IL-7 in fibrotic, but not in non-fibrotic pulmonary sarcoidosis. In contrast, compared to controls, there was a trend towards a significant increase in GM-CSF in non-fibrotic, but not in fibrotic pulmonary sarcoidosis.ConclusionsIn a comprehensive evaluation of circulating cytokines in sarcoidosis, we found IL-5, IL-7, and GM-CSF to be altered. These findings provide a window into the immunopathogenesis of sarcoidosis. IL-7 is a novel sarcoidosis cytokine and, as a master regulator of lymphocytes, is an attractive target for further studies. By observing an effect of phenotype upon cytokine patterns, we also identify specific immune alterations which may contribute to clinical heterogeneity. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
